Literature DB >> 32074440

Emicizumab in Hemophilia A.

Rebecca Kruse-Jarres1, Charles R M Hay2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32074440     DOI： 10.1056/NEJMc1916299

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.